PND31 a Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults With C1-Esterase-Inhibitor (C1-Inh) Deficiency
Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.497
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Elsevier BV